Disruptive technologies such as artificial intelligence (AI), big data and blockchain will impact the pharmaceutical industry, not only by helping to add value in terms of personalized treatment for patients, but also to counteract the unsustainability of skyrocketing drug prices, says GlobalData. Prescription drug prices, particularly in the US, have been skyrocketing over the past […]
This month, CEO Today had the pleasure to connect with Roel Bulthuis - the Managing Director of M Ventures (previously MS Ventures). The company is the strategic venture capital fund of Merck, which Roel established in 2009. M Ventures’ objective is to invest in innovative technologies and products with the potential to significantly impact Merck‘s […]
As part of our January Game Changers feature, this month CEO Today had the privilege to catch up with Renaud Dehareng - the CEO of the world’s largest global nuclear medicine company – Curium. Since becoming CEO in 2012, he has focused on developing Curium from a small European loss-making company into a successful global […]
CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.
